Vimarsana
Biggest News Aggregation in the World

Page 5 - Second Genome News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Second Genome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Second Genome Today - Breaking & Trending Today

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer - Vimarsana News

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer

Strategic executive hire adds to Company's global leadership team and positions the Company for continued growth DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ --Brii Biosciences Limited("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the appointment of Susannah Cantrell, Ph.D., as Chief Business Officer. Dr. Cantrell brings with her more than 20 years of healthcare and biotechnology industry experience spanni...

North America Accounts For Over Half Of The Microbiome Market - Vimarsana News

North America Accounts For Over Half Of The Microbiome Market

/PRNewswire/ -- North America was the largest region in the microbiome market, accounting for 56.0% of the total in 2021. It was followed by the Western...

The Business Research Company: North America Accounts For Over Half Of The Microbiome Market - Vimarsana News

The Business Research Company: North America Accounts For Over Half Of The Microbiome Market

The global microbiome market sees massive growth, with Asia Pacific catching up with North America at a growth rate of 49%. LONDON, April 7, 2022 /PRNewswire/ -- North America was the largest

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration - Vimarsana News

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,...

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration - Vimarsana News

Second Genome Announces Bayer Exercised Option Following Completion of Multi-Year Collaboration

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,...